发明名称 Fusion enzymes
摘要 The present disclosure relates to recombinant proteins having N-acetylglucosaminyltransferase activity. The present disclosure further relates to methods for producing complex N-glycans including the steps of providing host cells containing such recombinant proteins and culturing the host cells such that the recombinant proteins are expressed.
申请公布号 US9399764(B2) 申请公布日期 2016.07.26
申请号 US201113989084 申请日期 2011.11.24
申请人 Novartis International Pharmaceutical, Ltd.;Glykos Finland Oy 发明人 Natunen Jari;Kanerva Anne;Hiltunen Jukka;Saloheimo Markku;Viskari Heli;Huuskonen Anne
分类号 C12N9/10;C12P21/00;C12P19/18;C07K19/00;C12N15/80 主分类号 C12N9/10
代理机构 代理人 Halloran Patrick J.
主权项 1. A method of producing a complex N-glycan, comprising: (1) providing a filamentous fungal or yeast host cell, wherein the host cell comprises a polynucleotide encoding a fusion protein comprising an N-acetylglucosaminyltransferase I catalytic domain and an N-acetylglucosaminyltransferase II catalytic domain,wherein the N-acetylglucosaminyltransferase II catalytic domain is positioned N-terminal to the N-acetylglucosaminyltransferase I catalytic domain, andwherein the alg3 gene is deleted from the host cell; and (2) culturing the filamentous fungal or yeast host cell such that the fusion protein is expressed, wherein the fusion protein catalyzes the transfer of N-acetylglucosamine to a terminal Manα3 residue and N-acetylglucosamine to a terminal Manα6 residue of an acceptor glycan to produce a complex N-glycan.
地址 Hamilton BM